OPTIMER PHARMACEUTICALS INC Revenue
OPTIMER PHARMACEUTICALS INC reported Revenue of $20.07 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC revenues for the quarter ending 2013-06-30 was $20.07M, a 59.67% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC revenues for the quarter ending 2013-03-31 was $19.44M, a 35.13% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC revenues for the quarter ending 2012-12-31 was $19.52M, a 69.80% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC revenues for the quarter ending 2012-09-30 was $17.88M, a 61.74% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC revenues for fiscal 2012 was $101.53M, a 29.97% decline from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC revenues for fiscal 2011 was $144.98M, a 9693.44% increase from fiscal 2010.
- OPTIMER PHARMACEUTICALS INC revenues for fiscal 2010 was $1.48M, a 65.84% increase from fiscal 2009.
- OPTIMER PHARMACEUTICALS INC revenues for fiscal 2009 was $892.64K.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|---|
| 2013-06-30 | $20.07M 10-Q · filed 2013-08-07 | $39.50M 10-Q · filed 2013-08-07 | $59.02M derived: sum of 3 quarters · filed 2013-08-07 | $76.90M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2013-03-31 | $19.44M 10-Q · filed 2013-05-10 | $38.95M derived: sum of 2 quarters · filed 2013-05-10 | $56.83M derived: sum of 3 quarters · filed 2013-05-10 | $106.58M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-12-31 | $19.52M 10-K · filed 2013-03-18 | $37.39M derived: sum of 2 quarters · filed 2013-03-18 | $87.15M derived: sum of 3 quarters · filed 2013-08-07 | $101.53M 10-K · filed 2013-03-18 | |
| 2012-09-30 | $17.88M 10-K · filed 2013-03-18 | $17.88M 10-Q · filed 2012-11-02 | $67.63M derived: sum of 2 quarters · filed 2013-08-07 | $82.02M 10-Q · filed 2012-11-02 | $146.63M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | $49.76M 10-Q · filed 2013-08-07 | $64.14M 10-Q · filed 2013-08-07 | $128.76M derived: sum of 3 quarters · filed 2013-08-07 | $139.81M derived: sum of 4 quarters · filed 2013-08-07 | |
| 2012-03-31 | $14.38M 10-Q · filed 2013-05-10 | $79.00M derived: sum of 2 quarters · filed 2013-05-10 | $90.05M derived: sum of 3 quarters · filed 2013-05-10 | $90.08M derived: sum of 4 quarters · filed 2013-05-10 | |
| 2011-12-31 | $64.62M 10-K · filed 2013-03-18 | $75.67M derived: sum of 2 quarters · filed 2013-03-18 | $75.70M derived: sum of 3 quarters · filed 2013-03-18 | $144.98M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $11.05M 10-K · filed 2013-03-18 | $11.05M 10-Q · filed 2011-11-03 | $11.09M derived: sum of 2 quarters · filed 2013-03-18 | $80.36M 10-Q · filed 2012-11-02 | $80.52M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $33.00K 10-K · filed 2013-03-18 | $33.29K 10-Q · filed 2011-08-04 | $69.31M 10-Q · filed 2012-08-03 | $69.47M derived: sum of 3 quarters · filed 2013-03-18 | $70.14M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $69.28M 10-K · filed 2013-03-18 | $69.28M 10-Q · filed 2012-05-10 | $69.43M derived: sum of 2 quarters · filed 2013-03-18 | $70.10M derived: sum of 3 quarters · filed 2013-03-18 | $70.46M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $156.35K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $825.49K derived: sum of 2 quarters · filed 2013-03-18 | $1.18M derived: sum of 3 quarters · filed 2013-03-18 | $1.48M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $669.14K 10-Q · filed 2011-11-03 | $1.03M derived: sum of 2 quarters · filed 2011-11-03 | $1.32M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $357.44K 10-Q · filed 2011-08-04 | $654.87K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $892.64K 10-K · filed 2012-03-08 |